Deficiency of TMEM53 causes a previously unknown sclerosing bone disorder by dysregulation of BMP-SMAD signaling
Sclerosing bone disorder (SBD) includes a broad spectrum of monogenic diseases characterised by increased bone density. Here, the authors describe a previously unknown SBD in four families caused by mutations in TMEM53 and demonstrate the role this protein plays in BMP signalling during bone formati...
Main Authors: | Long Guo, Aritoshi Iida, Gandham SriLakshmi Bhavani, Kalpana Gowrishankar, Zheng Wang, Jing-yi Xue, Juan Wang, Noriko Miyake, Naomichi Matsumoto, Takanori Hasegawa, Yusuke Iizuka, Masashi Matsuda, Tomoki Nakashima, Masaki Takechi, Sachiko Iseki, Shinsei Yambe, Gen Nishimura, Haruhiko Koseki, Chisa Shukunami, Katta M. Girisha, Shiro Ikegawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-04-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-021-22340-8 |
Similar Items
-
Bi-allelic loss-of-function variants in TMEM53 cause a novel type of sclerosing bone disorder in human and mouse
by: Long Guo, et al.
Published: (2021-04-01) -
Cryo-EM structures of human TMEM120A and TMEM120B
by: Meng Ke, et al.
Published: (2021-08-01) -
Functional Swapping between Transmembrane Proteins TMEM16A and TMEM16F
by: Suzuki, Takayuki
Published: (2014) -
DIFFUSE SCLEROSING PNEUMOCYTOMA (SCLEROSING HAEMANGIOMA)
by: A. A. Sadovnikov, et al.
Published: (2017-04-01) -
Rôle du canal chlorure activé par le calcium TMEM16F dans la motricité et implication dans la sclérose latérale amyotrophique
by: Soulard, Claire
Published: (2019)